EcoDrugPlus

Ribosomal Protein L34

Ensembl ID : ENSECRG00000011673
Gene Symbol: RPL34
3 Cross references
356 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSECRG00000017234
Gene Symbol: RPL35
3 Cross references
271 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSECRG00000004668
Gene Symbol: RPL35A
3 Cross references
513 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSECRG00000016039
Gene Symbol: RPL36
3 Cross references
401 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSECRG00000013145
Gene Symbol: RPL36A
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSECRG00000005718
Gene Symbol: RPL37
3 Cross references
418 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSECRG00000017630
Gene Symbol: RPL38
3 Cross references
234 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSECRG00000014475
Gene Symbol: RPL39
3 Cross references
115 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSECRG00000017761
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSECRG00000019410
Gene Symbol: RPL5
3 Cross references
537 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSECRG00000020989
Gene Symbol: RPL6
3 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSECRG00000005442
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).